In a report titled ‘‘Saudi Arabia Next Generation Sequencing (NGS) Market Size, Share, Forecast, & Trends Analysis by Offering, Type, Application, End User – Forecast to 2031,’ Meticulous Research® projects the Saudi Arabian NGS market will grow to $50 million by 2031, with a CAGR of 10.1% from 2024 to 2031.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6002

Market Drivers

The increase in cancer diagnoses, expanding pharmaceutical research investment, and progress in genome mapping programs are driving the growth of the NGS market in Saudi Arabia. However, market growth faces challenges such as the high costs of NGS systems and data privacy concerns.

Growth Opportunities and Market Challenges

The increased adoption of NGS in hospitals and laboratories, coupled with government initiatives supporting genome sequencing, presents significant growth opportunities. However, challenges such as regulatory issues, a shortage of trained professionals, and data management complexities remain.

Consumables to Lead Offering Segment

The consumables segment is anticipated to hold the largest share of the market in 2024, representing 62.6% of the total. Consumables related to library preparation and target enrichment are expected to lead, accounting for 45% of the consumables market.

Targeted Genome Sequencing in Focus

Targeted genome sequencing is projected to dominate the Saudi NGS market by 2024, offering a cost-effective solution that minimizes irrelevant genetic data. This method has been widely adopted in research and clinical settings due to its precision.

Research Segment to Lead Applications

Research applications are expected to dominate the market by 2024, with a 56.9% share. Cancer research, in particular, will account for 49.4% of this segment. NGS is increasingly used in cancer research to identify actionable biomarkers for personalized therapies.

Hospitals and Diagnostic Labs to Lead End Users

Hospitals and diagnostic labs are expected to dominate the end-user segment by 2024, driven by growing adoption in clinical diagnostics. Supportive government policies under Saudi Vision 2030, aiming to enhance local genomic testing, will further boost market growth.

Quick Buy : https://www.meticulousresearch.com/Checkout/38511411

Key Players:

Some of the key players operating in Saudi Arabia NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Beijing Genomics Institute (BGI) (China), Bio-Rad Laboratories, Inc. (U.S.), and 10x Genomics, Inc. (U.S.).

Key Questions Answered in the Report-

What is the value of revenue generated by the sale of NGS instruments, consumables, and software’s in Saudi Arabia?
At what rate is the demand for NGS offerings projected to grow for the next five to seven years?
What is the historical market size and growth rate for Saudi Arabia NGS market?
What are the major factors impacting the growth of Saudi Arabia NGS market?
What are the major opportunities for existing players and new entrants in the market?
Which offering and end user segments create major traction for the manufacturers in this market?
What are the key trends in this market?
Who are the major players in Saudi Arabia NGS market? What are their specific product offerings in this market?
What recent developments have taken place in Saudi Arabia NGS market? What impact have these strategic developments created on the market?

Browse in Depth : https://www.meticulousresearch.com/product/saudi-arabia-ngs-market-6002

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research